These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7785487)

  • 1. The pathogenesis of rheumatoid arthritis and the development of therapeutic strategies for the clinical investigation of biologics.
    Panayi GS
    Agents Actions Suppl; 1995; 47():1-21. PubMed ID: 7785487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
    Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
    APMIS; 1997 Apr; 105(4):257-63. PubMed ID: 9164467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New directions for biological therapy in rheumatoid arthritis.
    Elliott MJ; Maini RN
    Int Arch Allergy Immunol; 1994; 104(2):112-25. PubMed ID: 8199454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future use of biologic agents alone and in combination for the treatment of rheumatoid arthritis.
    Strand V
    Z Rheumatol; 1998 Feb; 57(1):41-5. PubMed ID: 9566107
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N; Betts KA; Messali AJ; Skup M; Garg V
    Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-CD4 therapy in treatment of rheumatoid arthritis--have the die been cast?].
    Keysser G; Alpermann U; Burmester GR
    Z Rheumatol; 1998 Oct; 57(5):320-5. PubMed ID: 9864838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological therapies: a novel approach to the treatment of autoimmune disease.
    Fox DA
    Am J Med; 1995 Jul; 99(1):82-8. PubMed ID: 7598148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibody therapy for rheumatoid arthritis].
    Ishii T; Saeki Y
    Nihon Rinsho; 2002 Mar; 60(3):551-5. PubMed ID: 11904972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis: new developments in biologic therapy.
    Mahajan A; Sharma R; Khajuria R; Bardi GH; Kapoor B; Gupta V
    J Indian Med Assoc; 2006 Jun; 104(6):327-30. PubMed ID: 17058552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rheumatoid arthritis: Unraveling the conundrum.
    Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
    J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of new biologics on bone destruction in rheumatoid arthritis].
    Kazuyoshi S; Tanaka Y
    Clin Calcium; 2009 Mar; 19(3):372-80. PubMed ID: 19252247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to CD4.
    Breedveld FC
    Rheum Dis Clin North Am; 1998 Aug; 24(3):567-78. PubMed ID: 9710887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications and efficacy of biologics in inflammatory arthritis].
    Combe B
    Bull Acad Natl Med; 2012 Oct; 196(7):1279-92; discussion 1293. PubMed ID: 23815014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1995 May; 7(3):191-7. PubMed ID: 7612410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
    Sfikakis PP
    Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy in rheumatoid arthritis.
    Choy EH; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 May; 37(5):484-90. PubMed ID: 9651073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anti-CD4 antibody for treatment of chronic inflammatory arthritis.
    Emmrich F; Horneff G; Becker W; Lüke W; Potocnik A; Kanzy U; Kalden JR; Burmester G
    Agents Actions Suppl; 1991; 32():165-70. PubMed ID: 2069085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.
    Lorenz HM; Grünke M; Hieronymus T; Antoni C; Nüsslein H; Schaible TF; Manger B; Kalden JR
    J Rheumatol; 2000 Feb; 27(2):304-10. PubMed ID: 10685789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.